Omega Fund IV, L.P. 4
Accession 0000899243-18-020583
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 5:09 PM ET
Size
32.1 KB
Accession
0000899243-18-020583
Insider Transaction Report
- Purchase
Common Stock
2018-07-24$15.00/sh+266,667$4,000,005→ 266,667 total - Conversion
Common Stock
2018-07-24+994,688→ 1,261,355 total - Conversion
Common Stock
2018-07-24+1,013,547→ 4,854,783 total - Conversion
Series Seed Warrants (right to buy)
2018-07-24−25,000→ 0 total→ Series Seed Preferred Stock (25,000 underlying) - Conversion
Series Seed Preferred Stock
2018-07-24−100,000→ 0 total→ Common Stock (994,688 underlying) - Conversion
Series A Convertible Preferred Stock
2018-07-24−259,366→ 0 total→ Common Stock (2,579,881 underlying) - Conversion
Series B Convertible Preferred Stock
2018-07-24−101,896→ 0 total→ Common Stock (1,013,547 underlying) - Award
Common Stock Option
2018-07-19+13,500→ 13,500 totalExercise: $15.00→ Common Stock (13,500 underlying) - Conversion
Common Stock
2018-07-24+2,579,881→ 3,841,236 total - Conversion
Common Stock Warrants (right to buy)
2018-07-24+248,672→ 248,672 total→ Common Stock (248,672 underlying)
- Conversion
Common Stock
2018-07-24+2,579,881→ 3,841,236 total - Award
Common Stock Option
2018-07-19+13,500→ 13,500 totalExercise: $15.00→ Common Stock (13,500 underlying) - Conversion
Common Stock Warrants (right to buy)
2018-07-24+248,672→ 248,672 total→ Common Stock (248,672 underlying) - Conversion
Series B Convertible Preferred Stock
2018-07-24−101,896→ 0 total→ Common Stock (1,013,547 underlying) - Conversion
Common Stock
2018-07-24+994,688→ 1,261,355 total - Conversion
Series Seed Preferred Stock
2018-07-24−100,000→ 0 total→ Common Stock (994,688 underlying) - Conversion
Series Seed Warrants (right to buy)
2018-07-24−25,000→ 0 total→ Series Seed Preferred Stock (25,000 underlying) - Conversion
Series A Convertible Preferred Stock
2018-07-24−259,366→ 0 total→ Common Stock (2,579,881 underlying) - Purchase
Common Stock
2018-07-24$15.00/sh+266,667$4,000,005→ 266,667 total - Conversion
Common Stock
2018-07-24+1,013,547→ 4,854,783 total
- Purchase
Common Stock
2018-07-24$15.00/sh+266,667$4,000,005→ 266,667 total - Award
Common Stock Option
2018-07-19+13,500→ 13,500 totalExercise: $15.00→ Common Stock (13,500 underlying) - Conversion
Common Stock
2018-07-24+994,688→ 1,261,355 total - Conversion
Common Stock
2018-07-24+2,579,881→ 3,841,236 total - Conversion
Series Seed Preferred Stock
2018-07-24−100,000→ 0 total→ Common Stock (994,688 underlying) - Conversion
Series B Convertible Preferred Stock
2018-07-24−101,896→ 0 total→ Common Stock (1,013,547 underlying) - Conversion
Common Stock
2018-07-24+1,013,547→ 4,854,783 total - Conversion
Series Seed Warrants (right to buy)
2018-07-24−25,000→ 0 total→ Series Seed Preferred Stock (25,000 underlying) - Conversion
Common Stock Warrants (right to buy)
2018-07-24+248,672→ 248,672 total→ Common Stock (248,672 underlying) - Conversion
Series A Convertible Preferred Stock
2018-07-24−259,366→ 0 total→ Common Stock (2,579,881 underlying)
- Purchase
Common Stock
2018-07-24$15.00/sh+266,667$4,000,005→ 266,667 total - Conversion
Common Stock
2018-07-24+994,688→ 1,261,355 total - Conversion
Common Stock
2018-07-24+2,579,881→ 3,841,236 total - Conversion
Series A Convertible Preferred Stock
2018-07-24−259,366→ 0 total→ Common Stock (2,579,881 underlying) - Award
Common Stock Option
2018-07-19+13,500→ 13,500 totalExercise: $15.00→ Common Stock (13,500 underlying) - Conversion
Common Stock
2018-07-24+1,013,547→ 4,854,783 total - Conversion
Series Seed Warrants (right to buy)
2018-07-24−25,000→ 0 total→ Series Seed Preferred Stock (25,000 underlying) - Conversion
Common Stock Warrants (right to buy)
2018-07-24+248,672→ 248,672 total→ Common Stock (248,672 underlying) - Conversion
Series Seed Preferred Stock
2018-07-24−100,000→ 0 total→ Common Stock (994,688 underlying) - Conversion
Series B Convertible Preferred Stock
2018-07-24−101,896→ 0 total→ Common Stock (1,013,547 underlying)
- Conversion
Common Stock
2018-07-24+994,688→ 1,261,355 total - Conversion
Series Seed Warrants (right to buy)
2018-07-24−25,000→ 0 total→ Series Seed Preferred Stock (25,000 underlying) - Conversion
Common Stock
2018-07-24+2,579,881→ 3,841,236 total - Conversion
Series Seed Preferred Stock
2018-07-24−100,000→ 0 total→ Common Stock (994,688 underlying) - Award
Common Stock Option
2018-07-19+13,500→ 13,500 totalExercise: $15.00→ Common Stock (13,500 underlying) - Conversion
Common Stock Warrants (right to buy)
2018-07-24+248,672→ 248,672 total→ Common Stock (248,672 underlying) - Purchase
Common Stock
2018-07-24$15.00/sh+266,667$4,000,005→ 266,667 total - Conversion
Common Stock
2018-07-24+1,013,547→ 4,854,783 total - Conversion
Series A Convertible Preferred Stock
2018-07-24−259,366→ 0 total→ Common Stock (2,579,881 underlying) - Conversion
Series B Convertible Preferred Stock
2018-07-24−101,896→ 0 total→ Common Stock (1,013,547 underlying)
- Conversion
Common Stock
2018-07-24+1,013,547→ 4,854,783 total - Conversion
Series Seed Preferred Stock
2018-07-24−100,000→ 0 total→ Common Stock (994,688 underlying) - Purchase
Common Stock
2018-07-24$15.00/sh+266,667$4,000,005→ 266,667 total - Conversion
Series Seed Warrants (right to buy)
2018-07-24−25,000→ 0 total→ Series Seed Preferred Stock (25,000 underlying) - Award
Common Stock Option
2018-07-19+13,500→ 13,500 totalExercise: $15.00→ Common Stock (13,500 underlying) - Conversion
Common Stock
2018-07-24+2,579,881→ 3,841,236 total - Conversion
Common Stock Warrants (right to buy)
2018-07-24+248,672→ 248,672 total→ Common Stock (248,672 underlying) - Conversion
Series B Convertible Preferred Stock
2018-07-24−101,896→ 0 total→ Common Stock (1,013,547 underlying) - Conversion
Common Stock
2018-07-24+994,688→ 1,261,355 total - Conversion
Series A Convertible Preferred Stock
2018-07-24−259,366→ 0 total→ Common Stock (2,579,881 underlying)
Footnotes (6)
- [F1]The reported securities are beneficially owned by Omega Fund IV, L.P. ("Omega IV"). The reported securities may be deemed to be beneficially owned by each of Omega Fund IV GP, L.P. ("Omega IV GP"), as the general partner of Omega IV, and Omega Fund IV GP Manager, Ltd. ("Omega IV GP Manager"), as the general partner of Omega IV GP. Otello Stampacchia, Richard Lim and Anne-Mari Paster are all the shareholders and directors of Omega IV GP Manager and have shared voting and investment power over the shares held by Omega IV and, as a result, may each be deemed to beneficially own the reported securities. Otello Stampacchia is also a director of the issuer. Each of the Reporting Persons disclaims beneficial ownership of the reported securities, except to the extent of his, her or its pecuniary interest therein.
- [F2]The Series Seed Preferred Stock ("Series Seed") converted automatically into shares of the issuer's common stock on a 1-for-9.94688 basis upon the completion of the issuer's public offering of common stock pursuant the issuer's registration statement under the Securities Act of 1933, as amended, filed with the Commission on June 22, 2018, as subsequently amended (the "IPO"). The Series Seed had no expiration date.
- [F3]The Series A Convertible Preferred Stock ("Series A") converted automatically into shares of the issuer's common stock on a 1-for-9.94688 basis upon the completion of IPO. The Series A had no expiration date.
- [F4]The Series B Convertible Preferred Stock ("Series B") converted automatically into shares of the issuer's common stock on a 1-for-9.94688 basis upon the completion of IPO. The Series B had no expiration date.
- [F5]The Series Seed Warrants (the "Seed Warrants") converted automatically in warrants to purchase shares of the issuer's common stock (the "Common Stock Warrants") on a 1-for-9.94688 basis upon the completion of IPO. The exercise price of the Common Stock Warrants is $1.01 per share of the issuer's common stock. The Seed Warrants had no expiration date and the Common Stock Warrants have no expiration date.
- [F6]The Common Stock Options (the "Options") were granted to Otello Stampacchia in his capacity as a director of the issuer on July 19, 2018 (the "Grant Date") contingent upon the closing of the IPO, with 25% of the Options vesting on the first anniversary of the Grant Date and an additional 3.125% of the Options vesting each month thereafter for 24 months. The Options expire on the tenth anniversary of the Grant Date.
Documents
Issuer
Replimune Group, Inc.
CIK 0001737953
Related Parties
1- filerCIK 0001528382
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 5:09 PM ET
- Size
- 32.1 KB